latest news releases from the newsroom
VistaPrint to Present At the 2007 Goldman Sachs Internet Conference
HAMILTON, Bermuda, April 30, 2007 (PRIME NEWSWIRE) -- VistaPrint Limited (Nasdaq:VPRT), the leading online supplier of high-quality graphic design services and customized printed products to small businesses and consumers, today announced that Robert Keane, president and chief executive officer, and Harpreet Grewal, executive vice president and chief financial officer, will present at the 2007 Goldman Sachs 8th Annual Internet Conference on May 23rd, 2007, in Las Vegas, Nevada.
KCAP Financial, Inc.
Kohlberg Capital Corporation 2007 First Quarter Results Conference Call Scheduled for Friday, May 11, 2007
NEW YORK, April 30, 2007 (PRIME NEWSWIRE) -- Kohlberg Capital Corporation (Nasdaq:KCAP) ("Kohlberg Capital") is scheduled to report financial results for the first quarter ended March 31, 2007 after close of Market on Thursday, May 10, 2007. On Friday, May 11, 2007 at 9:00 a.m. Eastern Standard Time, the Kohlberg Capital executive management team will host a conference call and audio webcast highlighting the Company's first quarter results. Shareholders, prospective shareholders and analysts are welcome to listen to the call or attend the webcast. The conference call dial-in number is 1-800-811-8824.
Summit Financial Group, Inc.
Summit Financial Group Announces First Half 2007 Semi-Annual Dividend
MOOREFIELD, W. Va., April 30, 2007 (PRIME NEWSWIRE) -- Summit Financial Group, Inc. (Nasdaq:SMMF), a $1.25 billion financial holding company headquartered in Moorefield, West Virginia, today announces its first half 2007 semi-annual cash dividend. The dividend will be $0.17 per share and is payable on June 15, 2007 to shareholders of record as of June 1, 2007. This dividend represents an increase of 6.25% over the $0.16 per share paid in the first half of 2006.
I.D. Systems, Inc.
I.D. Systems, Inc. to Announce Q1 2007 Financial Results On May 3, 2007
HACKENSACK, N.J., April 30, 2007 (PRIME NEWSWIRE) -- I.D. Systems, Inc. (Nasdaq:IDSY) will be holding its quarterly financial results conference call for investors and analysts on May 3, 2007 at 4:45 p.m. ET. The financial results announcement is scheduled to cross the wire shortly after the market close on May 3, 2007. I.D. Systems, Inc. is sending out this release regarding Q1-2007 to comply with Federal Regulations FD.
GenTek Inc. Announces Earnings Call Friday, May 11, 2007, 11 A.M. E.T.
PARSIPPANY, N.J., April 30, 2007 (PRIME NEWSWIRE) -- GenTek Inc. (Nasdaq:GETI) has scheduled a conference call on Friday, May 11, 2007 at 11 a.m. Eastern Time to review its financial results for the first quarter ended March 31, 2007. Remarks by William E. Redmond, Jr., President and Chief Executive Officer of GenTek Inc. and by Thomas B. Testa, Vice President and Chief Financial Officer of the Company will be followed by a Q & A session. The call may be accessed by dialing toll free 800-289-0572. Callers are advised to dial into the call at least ten minutes prior to the scheduled start time.
Izard Nobel LLP
Schatz Nobel Izard, P.C. Announces Class Action Lawsuit Against International Rectifier Corporation
HARTFORD, Conn., April 30, 2007 (PRIME NEWSWIRE) -- The law firm of Schatz Nobel Izard, P.C., which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the Central District of California on behalf of all persons who purchased or otherwise acquired the common stock of International Rectifier Corporation ("IRF" or the "Company") (NYSE:IRF) between October 27, 2005 and April 9, 2007, inclusive, (the "Class Period").
Integrated BioPharma, Inc.
Integrated Biopharma Announces Progress Toward Development of Reagents for Diabetes Diagnostic
HILLSIDE, NJ, April 30, 2007 (PRIME NEWSWIRE) -- InB:Biotechnologies, Inc. ("INB:B"), a wholly-owned subsidiary of Integrated BioPharma (Nasdaq:INBP), announced today that it successfully produced a bioequivalent diabetes-associated autoantigen using INBP's novel, proprietary AIPwLV platform technology. The study was conducted by the Fraunhofer USA Center for Molecular Biotechnology (CMB), the Contract Research Organization led by Dr. Vidadi Yusibov, through which INB:B executes its vaccine and other biopharmaceutical development activities.